0001206774-24-000070.txt : 20240201
0001206774-24-000070.hdr.sgml : 20240201
20240201184756
ACCESSION NUMBER: 0001206774-24-000070
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240201
FILED AS OF DATE: 20240201
DATE AS OF CHANGE: 20240201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALKEON CAPITAL MANAGEMENT LLC
CENTRAL INDEX KEY: 0001230239
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41944
FILM NUMBER: 24588327
BUSINESS ADDRESS:
STREET 1: 350 MADISON AVENUE
STREET 2: 20TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 2127166576
MAIL ADDRESS:
STREET 1: 350 MADISON AVENUE
STREET 2: 20TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alto Neuroscience, Inc.
CENTRAL INDEX KEY: 0001999480
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 834210124
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 369 SOUTH SAN ANTONIO RD.
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
BUSINESS PHONE: 773-255-5012
MAIL ADDRESS:
STREET 1: 369 SOUTH SAN ANTONIO RD.
CITY: LOS ALTOS
STATE: CA
ZIP: 94022
3
1
ownership.xml
X0206
3
2024-02-01
0
0001999480
Alto Neuroscience, Inc.
ANRO
0001230239
ALKEON CAPITAL MANAGEMENT LLC
350 MADISON AVENUE
NEW YORK
NY
100017
1
0
0
1
See Remarks
Series B Preferred Stock
Common Stock
392598
D
Series C Preferred Stock
Common Stock
84503
D
Each share of Series B Preferred Stock is convertible at any time, at the holder's election, and will automatically convert into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering on a 2.1226069 for 1 basis into the number of shares of Common Stock shown in column 3 and has no expiration date.
Shares held by IJS Global Holdings, Ltd. ("IJS"). The Reporting Person is the investment adviser of IJS, and the Reporting Person disclaims any beneficial ownership of any and all of the Issuer's securities reported herein in excess of its actual pecuniary interest.
Each share of Series C Preferred Stock is convertible at any time, at the holder's election, and will automatically convert into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering on a 2.2241 for 1 basis into the number of shares of Common Stock shown in column 3 and has no expiration date.
The Reporting Person may be deemed to be a director by deputization for purposes of Section 16 under the Securities Exchange Act of 1934 by virtue of the fact that Po Yu (Jeff) Chen, an employee of the Reporting Person, currently serves on the board of directors of the Issuer.
/s/ Alkeon Capital Management, LLC, by Jennifer Shufro, Managing Director
2024-02-01